Association of the British Pharmaceutical Industry

Knowledge Source Identification
Knowledge source name Association of the British Pharmaceutical Industry
Abbreviated name ABPI
Owner/Developer Association of the British Pharmaceutical Industry
Abbreviated owner ABPI
Country United Kingdom
Languages English
Description The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK. The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK. We maintain close contacts with Government, politicians, academia and the media and we also have extensive links with health managers, patient advocacy groups, training and education bodies, research councils and other professional bodies in the healthcare field. The ABPI supports research using animals where alternative methods are not available, where the potential benefits to health are compelling, and where acceptable ethical and welfare standards can be met. We believe the European Directive 2010/63/EU has enhanced animal welfare standards and introduced the concepts of refinement, replacement and reduction across the EU, while ensuring Europe remains a world leader in biomedical research.
Knowledge Source Category
Category Organization
Sub categories Industry, Non-Governmental Organization
Knowledge Dissemination and Sharing
Dissemination channel Website, Social media, Audio / Video, Professional online network
Targeted audience (specified/objective analysis) Regulators, Industry
Users access Open access, User registration
Knowledge Characterization
3Rs relevance Replacement, Reduction, Refinement
Purpose Education and training, Documentation and information
Legislative framework Directive 2010/63/EU, Medicines legislation